ArticleBMC cancer2017

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.

Beate Jahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.